Stay updated on Belantamab vs Bortezomib in MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.

Latest updates to the Belantamab vs Bortezomib in MM Clinical Trial page
- Check6 days agoChange DetectedThe page now includes a 'Multiple myeloma' topic tag and expands the related topics to include 'MedlinePlus Genetics'. The revision stamp was updated from v3.6.4 to v3.6.5.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision: v3.6.4 is now shown, replacing v3.6.3. This reflects a platform release update and does not modify the study content.SummaryDifference0.0%

- Check28 days agoChange DetectedThe page no longer displays the 'Multiple myeloma' disease label, the 'related topics:' header, and the MedlinePlus Genetics link. This reduces visible disease context and related resource references for users.SummaryDifference0.1%

- Check35 days agoChange DetectedThis change adds a 'Multiple myeloma' topic tag and a 'related topics' section linking to MedlinePlus Genetics, providing additional context and resources related to the study's disease area.SummaryDifference0.1%

- Check42 days agoChange DetectedA new revision (v3.6.3) was added, replacing the previous revision (v3.6.2), indicating a small platform update rather than a change to the study details.SummaryDifference0.0%

- Check49 days agoChange DetectedRevision: v3.6.2 is now shown on the page, and the items 'Multiple myeloma', 'related topics:', 'MedlinePlus Genetics', and 'Revision: v3.6.0' were removed.SummaryDifference0.1%

Stay in the know with updates to Belantamab vs Bortezomib in MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab vs Bortezomib in MM Clinical Trial page.